Trial intelligence / Profile preview

Traumeel S for Pain After Knee and Hip Arthroplasty

NCT00307853Phase 3Terminated

Sponsor
Shaare Zedek Medical Center
Start
Aug 2008
Primary completion
Aug 2009
Modality
Botanical Extract
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative pain comparing Traumeel S with Placebo (2 arms). Primary endpoint: Cumulative 48-hour postoperative morphine consumption. Started Aug 2008; status: terminated.

02

Drugs

Traumeel S
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00307853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00307853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call